214 related articles for article (PubMed ID: 26094393)
21. Age-related androgen deficiency and type 2 diabetes.
Ryan GJ; Jobe LJ
J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855
[TBL] [Abstract][Full Text] [Related]
22. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
[TBL] [Abstract][Full Text] [Related]
23. Androgen deficiency and hormone-replacement therapy.
Isidori AM; Greco EA; Aversa A
BJU Int; 2005 Aug; 96(2):212-6. PubMed ID: 16001962
[No Abstract] [Full Text] [Related]
24. [Andropause].
Hochreiter WW; Ackermann DK; Brütsch HP
Ther Umsch; 2005 Dec; 62(12):821-6. PubMed ID: 16405287
[TBL] [Abstract][Full Text] [Related]
25. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
Amano T
Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
[TBL] [Abstract][Full Text] [Related]
26. [Correction of cardiovascular pathology in men with age-dependent androgen deficiency (review)].
Ametov AS; Vertkin AL; Morgunov LIu; Arinina EN; Naumov AV
Ter Arkh; 2007; 79(10):50-3. PubMed ID: 18154146
[No Abstract] [Full Text] [Related]
27. Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations.
Liu PY; Swerdloff RS; Veldhuis JD
J Clin Endocrinol Metab; 2004 Oct; 89(10):4789-96. PubMed ID: 15472164
[TBL] [Abstract][Full Text] [Related]
28. Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency.
Corrales JJ; Almeida M; Miralles JM; Orfao A
Fertil Steril; 2009 Jul; 92(1):311-9. PubMed ID: 18710716
[TBL] [Abstract][Full Text] [Related]
29. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
Boyanov MA; Boneva Z; Christov VG
Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
[TBL] [Abstract][Full Text] [Related]
30. Androgen deficiency in the aging male.
Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Male Reproduction and Urology
Fertil Steril; 2008 Nov; 90(5 Suppl):S83-7. PubMed ID: 19007654
[TBL] [Abstract][Full Text] [Related]
31. Alternatives to testosterone replacement: testosterone restoration.
McCullough A
Asian J Androl; 2015; 17(2):201-5. PubMed ID: 25578932
[TBL] [Abstract][Full Text] [Related]
32. [Testosterone replacement therapy for androgen deficiency syndrome].
Altarac S
Lijec Vjesn; 2011; 133(3-4):147. PubMed ID: 21612113
[No Abstract] [Full Text] [Related]
33. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
Lunenfeld B; Saad F; Hoesl CE
Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
[TBL] [Abstract][Full Text] [Related]
34. Androgen replacement in women: a commentary.
Davis S
J Clin Endocrinol Metab; 1999 Jun; 84(6):1886-91. PubMed ID: 10372681
[TBL] [Abstract][Full Text] [Related]
35. Androgen therapy in women: for whom and when.
Pluchino N; Carmignani A; Cubeddu A; Santoro A; Cela V; Errasti T
Arch Gynecol Obstet; 2013 Oct; 288(4):731-7. PubMed ID: 23912530
[TBL] [Abstract][Full Text] [Related]
36. Androgen effect on insulin action and glucose metabolism.
Rizza RA
Mayo Clin Proc; 2000 Jan; 75 Suppl():S61-4. PubMed ID: 10959219
[TBL] [Abstract][Full Text] [Related]
37. Controversies in testosterone supplementation therapy.
Khera M
Asian J Androl; 2015; 17(2):175-6. PubMed ID: 25652639
[TBL] [Abstract][Full Text] [Related]
38. Androgen deficiency in the etiology and treatment of erectile dysfunction.
Gore JL; Swerdloff RS; Rajfer J
Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
[TBL] [Abstract][Full Text] [Related]
39. Testosterone replacement and the physiologic aspects of aging in men.
Morley JE
Mayo Clin Proc; 2000 Jan; 75 Suppl():S83-7. PubMed ID: 10959223
[TBL] [Abstract][Full Text] [Related]
40. Formulations and use of androgens in women.
Chu MC; Lobo RA
Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S3-7. PubMed ID: 15065631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
